• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.子宫颈、子宫体和卵巢恶性肿瘤的流行病学——当前数据及流行病学趋势
Geburtshilfe Frauenheilkd. 2013 Feb;73(2):123-129. doi: 10.1055/s-0032-1328266.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.北欧国家女性生殖器官癌症患者的生存趋势 1964-2003 年随访至 2006 年底。
Acta Oncol. 2010 Jun;49(5):632-43. doi: 10.3109/02841861003691945.
4
Gynaecological Malignancies Among a Representative Population of Batticaloa, Sri Lanka.斯里兰卡拜蒂克洛代表性人群中的妇科恶性肿瘤
Cureus. 2021 Jan 27;13(1):e12947. doi: 10.7759/cureus.12947.
5
Survival of gynecological cancers in Turkey: where are we at?土耳其妇科癌症的生存率:我们目前的状况如何?
J Gynecol Oncol. 2017 Nov;28(6):e85. doi: 10.3802/jgo.2017.28.e85.
6
Epidemiology of breast and gynaecological cancers in Poland.波兰乳腺癌和妇科癌症的流行病学
Eur J Gynaecol Oncol. 1993;14 Suppl:40-7.
7
Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group.1978 - 1989年期间欧洲妇科肿瘤女性患者的生存率。欧洲癌症治愈研究与评估协作组
Eur J Cancer. 1998 Dec;34(14 Spec No):2218-25. doi: 10.1016/s0959-8049(98)00326-8.
8
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
9
[Descriptive epidemiology and prognosis of malignant gynecologic tumors].[妇科恶性肿瘤的描述性流行病学及预后]
Geburtshilfe Frauenheilkd. 1989 Jun;49(6):573-8. doi: 10.1055/s-2008-1035842.
10
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.日本妇科癌症趋势:1980 年至 2019 年的发病率和 1981 年至 2021 年的死亡率。
Int J Clin Oncol. 2024 Apr;29(4):363-371. doi: 10.1007/s10147-024-02473-8. Epub 2024 Feb 21.

引用本文的文献

1
Collagen type IV alpha 6 promotes tumor progression and chemoresistance in ovarian cancer by activating the discoidin domain receptor 1 pathway.IV型胶原蛋白α6通过激活盘状结构域受体1途径促进卵巢癌的肿瘤进展和化疗耐药性。
Oncogenesis. 2025 Jul 2;14(1):23. doi: 10.1038/s41389-025-00565-2.
2
A histopathological review of gynaecological malignancies in Katsina state North-Western Nigeria.尼日利亚西北部卡齐纳州妇科恶性肿瘤的组织病理学回顾
Ecancermedicalscience. 2024 Aug 29;18:1750. doi: 10.3332/ecancer.2024.1750. eCollection 2024.
3
Association between gynecologic cancer and Alzheimer's disease: a bidirectional mendelian randomization study.妇科癌症与阿尔茨海默病之间的关联:一项双向孟德尔随机化研究。
BMC Cancer. 2024 Aug 21;24(1):1032. doi: 10.1186/s12885-024-12787-5.
4
circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.环状 RNA 结构特异性核酸酶 DENND4C 是一种新型的上皮性卵巢癌血清标志物,通过下调 miR-200b/c 发挥肿瘤抑制作用。
Ann Med. 2023 Dec;55(1):908-919. doi: 10.1080/07853890.2023.2185289.
5
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.circ_0025033 通过调控 hsa-miR-370-3p/SLC1A5 轴促进卵巢癌细胞的发展。
Cell Mol Biol Lett. 2022 Oct 22;27(1):94. doi: 10.1186/s11658-022-00364-2.
6
Integration of Transcriptome and Epigenome to Identify and Develop Prognostic Markers for Ovarian Cancer.整合转录组和表观基因组以鉴定和开发卵巢癌的预后标志物。
J Oncol. 2022 Aug 30;2022:3744466. doi: 10.1155/2022/3744466. eCollection 2022.
7
Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors.环状RNA在肿瘤顺铂耐药中的作用及机制研究进展
Front Pharmacol. 2021 Sep 9;12:709324. doi: 10.3389/fphar.2021.709324. eCollection 2021.
8
Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments.基于生物信息学和实验,鉴定溶质载体家族27A分子(SCL27As)作为卵巢癌的潜在生物标志物。
Ann Transl Med. 2021 Aug;9(15):1237. doi: 10.21037/atm-21-3026.
9
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.晚期浆液性卵巢癌新型肿瘤微环境预后标志物的鉴定
Cancers (Basel). 2021 Jul 3;13(13):3343. doi: 10.3390/cancers13133343.
10
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.基于脂质代谢表达谱的新型 11 基因浆液性卵巢癌预后模型的建立和验证。
Int J Mol Sci. 2020 Dec 1;21(23):9169. doi: 10.3390/ijms21239169.

本文引用的文献

1
Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias.人乳头瘤病毒基因分型在子宫颈肿瘤筛查、治疗及管理中的重要性
Geburtshilfe Frauenheilkd. 2012 Jun;72(6):507-512. doi: 10.1055/s-0032-1314959.
2
Diabetes increases the risk of breast cancer: a meta-analysis.糖尿病增加乳腺癌风险:一项荟萃分析。
Endocr Relat Cancer. 2012 Nov 19;19(6):793-803. doi: 10.1530/ERC-12-0242. Print 2012 Dec.
3
Survival of cervical cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage.21 世纪初德国宫颈癌患者的生存情况:按年龄、组织学和分期的时期分析。
Acta Oncol. 2012 Sep;51(7):915-21. doi: 10.3109/0284186X.2012.708105. Epub 2012 Aug 29.
4
Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.全球范围内子宫颈鳞状细胞癌和腺癌的发病率及死亡率趋势
Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):645-50.
5
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.欧洲癌症的近期趋势:自20世纪90年代以来17种癌症部位发病率、生存率和死亡率的综合研究方法
Eur J Cancer. 2008 Jul;44(10):1345-89. doi: 10.1016/j.ejca.2007.12.015. Epub 2008 Feb 14.
6
The epidemiology of human papillomavirus infection and cervical cancer.人乳头瘤病毒感染与宫颈癌的流行病学
Dis Markers. 2007;23(4):213-27. doi: 10.1155/2007/914823.
7
Human papillomavirus and cervical cancer: burden of illness and basis for prevention.人乳头瘤病毒与宫颈癌:疾病负担及预防依据
Am J Manag Care. 2006 Dec;12(17 Suppl):S462-72.
8
Endometrial cancer.子宫内膜癌
Lancet. 2005;366(9484):491-505. doi: 10.1016/S0140-6736(05)67063-8.
9
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.在全球范围内,人乳头瘤病毒是浸润性宫颈癌的必要病因。
J Pathol. 1999 Sep;189(1):12-9. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.

子宫颈、子宫体和卵巢恶性肿瘤的流行病学——当前数据及流行病学趋势

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.

作者信息

Waldmann A, Eisemann N, Katalinic A

机构信息

Institut für Sozialmedizin und Epidemiologie, Lübeck.

Institut für Krebsepidemiologie e. V., Lübeck.

出版信息

Geburtshilfe Frauenheilkd. 2013 Feb;73(2):123-129. doi: 10.1055/s-0032-1328266.

DOI:10.1055/s-0032-1328266
PMID:24771908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3859169/
Abstract

Cervical, uterine and ovarian cancers are the most common malignancies of the female genital tract. Using current data from population-based cancer registries in Germany, we present the recent figures for the incidence, prevalence, associated mortality and survival for these cancers. In 2009, a total of 23 800 women were newly diagnosed with one of the three gynaecological cancers (cervical cancer: 20.3 %, endometrial cancer: 48.5 %, ovarian cancer: 31.2 %). This figure equals approximately one third of the number of women newly diagnosed with breast cancer in the same year. The relative 5-year survival for carcinomas of the corpus uteri is 79 % and is higher that those for cervical cancer (68 %) and ovarian cancer (40 %). Ovarian cancer in particular is often diagnosed at a later stage and has a high risk of recurrence. Due to the favourable prognosis for endometrial tumours and the unfavourable prognosis for ovarian malignancies, the incidence of various gynaecological tumours is ranked differently compared to the 5-year prevalence of these same tumours. Currently, the 5-year prevalence in Germany for patients with cervical, endometrial or ovarian cancer is estimated to be around 80 000 women. Slightly more than half of these women were diagnosed with cancer of the corpus uteri. Around 25 % of women have ovarian and 21 % have cervical cancer.

摘要

宫颈癌、子宫癌和卵巢癌是女性生殖道最常见的恶性肿瘤。利用德国基于人群的癌症登记处的现有数据,我们展示了这些癌症的发病率、患病率、相关死亡率和生存率的最新数据。2009年,共有23800名女性被新诊断出患有三种妇科癌症中的一种(宫颈癌:20.3%,子宫内膜癌:48.5%,卵巢癌:31.2%)。这个数字约等于同年新诊断出患有乳腺癌的女性人数的三分之一。子宫体癌的相对5年生存率为79%,高于宫颈癌(68%)和卵巢癌(40%)。特别是卵巢癌往往在较晚阶段被诊断出来,且复发风险高。由于子宫内膜肿瘤的预后良好而卵巢恶性肿瘤的预后不良,各种妇科肿瘤的发病率与这些相同肿瘤的5年患病率排名不同。目前,德国宫颈癌、子宫内膜癌或卵巢癌患者的5年患病率估计约为80000名女性。这些女性中略多于一半被诊断出患有子宫体癌。约25%的女性患有卵巢癌,21%患有宫颈癌。